November 6 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said it turned to a net loss of 11.6 million marka ($6.4 million/5.9 million euro) in the first nine months of 2023 after booking a net profit of 24.9 million marka in the like period last year.